Sulzer Assessing Public Tender Offer by InCentive Capital AG
On Monday February 19, 2001, Sulzer Ltd was informed concurrently with public announcement of a takeover bid by the Swiss investment company InCentive Capital AG, Zug. The Sulzer Board of Directors is currently assessing in detail this offer to Sulzer shareholders.
The Sulzer Board of Directors has taken note of the preliminary announcement of a public tender offer by InCentive Capital AG, and is now assessing in detail the announced offer. Sulzer will disclose its standpoint in due course. Until then, Sulzer will make no further commentary on this takeover bid.
Sulzer, founded 1834 in Winterthur (CH), is an internationally active technology corporation. The medical technology group develops, manufactures and markets medical implants and biological materials for orthopedic and cardiovascular applications. The industrial activities feature coating technologies, process technology, pumps and compressors, weaving machines, as well as infrastructure solutions for buildings. In 1999, the Sulzer Corporation turned over some 5500 million CHF.